Tilray Brands Inc (NASDAQ:TLRY) on Monday announced that Aphria RX GmbH received a trading license in Germany.

What Happened: Tilray’s Aphria has received a trading license that will allow it to sell and distribute a broad range of medical cannabis products to pharmacies, hospitals and medical wholesalers throughout Germany.

“We remain dedicated to advocating for responsible cannabis regulations, education and research and accessibility to high-quality medical cannabis.”

Tilray believes these developments will have a positive impact on the health and wellbeing of patients in Germany. The company also noted that it’s now in a strong position to fully leverage the growing market opportunity in Germany, further expanding its position as a global leader in cannabis research, cultivation, production and distribution.

See Also: Sha’Carri Richardson’s Olympic Return: The Cannabis Debate Amid US-WADA Tensions Over Doping Laws

How To Buy TLRY Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Tilray Brands’ case, it’s in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

TLRY Price Action: Tilray shares were up 0.55% at $1.84 at the time of publication, according to Benzinga Pro.

Photo: 7raysmarketing from Pixabay.